Adult Bovine Serum Market, by Origin (North America-sourced, Australia-sourced, New Zealand-sourced, and Others (South America-sourced, etc.)), by Application (Commercial Purpose and Research Purpose), by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, and Others (Diagnostics Laboratories, Forensic Labs, etc.)), and by Region (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Adult bovine serum (ABS) is obtained from slaughtered adult cows. The serum is separated from the blood of adult cows more than 12 months old by mechanical defibrination process. It has double the protein level of FBS (fetal bovine serum) and contains more immunoglobulins. ABS contains a low amount of hemoglobin. ABS is often used to increase growth and proliferation of different cell types in basal cell culture media. Bovine blood taken from slaughtered cows is recycled to make a variety of products including food additives, pet food, adhesives, cosmetics, biological reagents, and pharmaceutical intermediates. Among these, serum for cell culture is the most extensively utilized product made from cow blood. The serum obtained during the slaughtering process is considered to be biologically safe for mammalian cell cultures.
Market Dynamics
Numerous benefits of using adult bovine serum for various applications such as cell culture media, vaccine production, diagnostic assays, etc. and increasing Research and development (R&D) activities for evaluating the efficiency of adult bovine serum are propelling the adult bovine serum market growth. Moreover, market players are focused on expanding vaccine manufacturing facilities, which would increase the use of adult bovine serum and drive market growth over the forecast period. For instance, in October 2021, the U.S. International Development Finance Corporation (DFC), the development bank of the U.S., and Biological E. Limited, an India-based pharmaceuticals & biologics company, announced their partnership for the expansion of Biological E.’s vaccine manufacturing facility in Hyderabad, India to produce COVID-19 vaccines. This partnership would help boost COVID-19 response efforts and also benefit long-term global health in India and throughout the Indo-Pacific region.
Key features of the study:
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook